When associated with FXS, autism is caused by the genetic change or mutation in the Fragile X gene—the most common genetic cause of autism. Tune in to learn about emerging research on Fragile X and ASD.
About the speaker:

Randi Hagerman, MD
Randi Hagerman, M.D., is medical director of the UC Davis MIND Institute and director of the Fragile X Research and Treatment Center. She has more than 20 years of experience in the field of neurodevelopmental disorders and is an internationally respected leader in fragile X research including fragile X syndrome, a genetic condition that is the leading cause of inherited intellectual disability and the leading single-gene cause of autism.
Dr. Hagerman, her husband, Dr. Paul Hagerman, and their research team are the discoverers of Fragile X-associated Tremor/Ataxia Syndrome (FXTAS), a late-onset neurodegenerative disorder. Randi Hagerman conducts clinical research on individuals with fragile X-associated disorders, including children and adults with fragile X syndrome, adult males with FXTAS, and women with fragile-X related conditions, such as fragile X-associated primary ovarian insufficiency (FXPOI).
Dr. Hagerman also conducts research that bridges the association between autism and fragile X syndrome. Her main area of research is on targeted treatments for neurodevelopmental disorders, including fragile X syndrome, autism, premutation disorders and Angelman syndrome.
Take the knowledge quiz
Can’t see the quiz below? Take it online HERE
Gene Therapy for Mutations in the IQSEC2 Gene
The IQSEC2 protein is a guanine nucleotide exchange factor for Arf6. Pathogenic variants in the X-linked IQSEC2 gene are associated with drug-resistant epilepsy, severe intellectual disability, and autism. The vast
Towards the Development of a Diagnostic Test for Autism Spectrum Disorder: Data Science Meets Metabolomics
Hear Juergen Hahn, Ph.D., ARI Scientific Advisory Board member, discuss how using machine learning can lead to biomarker discoveries in autism research. Handouts are online HERE
How Genetics is Shaping the Field of Autism Research
Learn about how research on genetic influences is shaping our understanding of autism. About the speaker: M. Pilar Trelles, MD, is a licensed and
Breakthroughs in Understanding roles of Genes and Environment in Autism
About the speaker: Dr. Jonathan Sebat, Director, Beyster Center for Psychiatric Genomics Dr. Sebat leads an interdisciplinary team in the clinical and genomic analysis of
The Low-Hanging Fruit: Exploring Monogenic Syndromes with Elevated Rates of Autism
Dr. Daniel Vogt, Ph.D., explores monogenic syndromes and what they can tell us about the underlying causes of autism. He describes signaling pathways critical in early development, highlighting the electrical nature of
Biomarkers start telling us a story: Autism pathophysiology revisited
This is a joint presentation with the World Autism Organisation. Antonio Persico, MD, a recent ARI Research Grant recipient, explores the role of biomarkers in understanding autism pathophysiology. He



